Peter F. Lang
Director of Finance/CFO at OPTHEA LIMITED
Profile
Peter F.
Lang is currently the Chief Financial Officer at Opthea Ltd.
He was previously a Managing Director & Partner at Ridge Advisory LLC and the Chief Financial Officer at Aerie Pharmaceuticals, Inc. for a brief period in 2022.
Lang holds an MBA from The University of Chicago Booth School of Business and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Peter F. Lang active positions
| Companies | Position | Start |
|---|---|---|
| OPTHEA LIMITED | Director of Finance/CFO | 2023-10-26 |
Former positions of Peter F. Lang
| Companies | Position | End |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | 2022-11-20 |
| Ridge Advisory LLC | Corporate Officer/Principal | - |
Training of Peter F. Lang
| The University of Chicago Booth School of Business | Masters Business Admin |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
| Ridge Advisory LLC | Commercial Services |
- Stock Market
- Insiders
- Peter F. Lang
